Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vyvanse in Adolescents with ADHD and Substance-Dependent Siblings
NCT00573534Phase 4Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Mar 2008
- Primary completion
- Jan 2010
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of lisdexamfetamine in attention deficit hyperactivity disorder (ADHD), sponsored by New York State Psychiatric Institute. Started Mar 2008; status: completed.
02
Drugs
lisdexamfetamine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00573534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00573534.